Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients

Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients

Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma